Onchocerciasis (River Blindness) Ongoing Global Clinical Trials Analysis and Outlook

  • ID: 4584880
  • Report
  • Region: Global
  • 29 pages
  • VPA Research
1 of 3
Onchocerciasis (River Blindness) ongoing clinical trials report provides comprehensive analysis and trends in global Onchocerciasis (River Blindness) disease clinical trials. The research work analyzes the ongoing Onchocerciasis (River Blindness) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Onchocerciasis (River Blindness) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Onchocerciasis (River Blindness) clinical trials.

Scope of the Report:
  • Ongoing Onchocerciasis (River Blindness) clinical trials across regions
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Onchocerciasis (River Blindness)
  • Both observational and interventional trials analyzed
  • Leading companies and universities participating in Onchocerciasis (River Blindness) clinical trials
Reasons to Buy:
  • Track competition and design competitive advantages
  • Identify right partners to associate with for further research
  • Evaluate potential opportunities available in further clinical trials of the disease
  • Formulate business development strategies through success rates of clinical trials
  • Identify quick markets for recruiting subjects based on trials count by each market
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Table of Contents
1.1 List of Figures
1.2 List of Tables

2 Key Findings, 2018
2.1 Snapshot
2.2 Overview of Onchocerciasis (River Blindness) Trials

3 Clinical Trials Trends to 2022
3.1 Ongoing Onchocerciasis (River Blindness) Trials by Phase
3.2 Ongoing Onchocerciasis (River Blindness) Trials by Type
3.3 Ongoing Onchocerciasis (River Blindness) Trials by Recruitment Status

4 Country Level Analysis
4.1 Region wise Ongoing Onchocerciasis (River Blindness) Trials
4.2 Top 10 Countries conducting Onchocerciasis (River Blindness) Trials
4.3 Trials in Emerging and Developing Economies

5 Company Level Analysis
5.1 Ongoing Onchocerciasis (River Blindness) Trials by Sponsor Type
5.2 Onchocerciasis (River Blindness) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 Enrolment Trends to 2022
6.1 Subjects Recruited for Onchocerciasis (River Blindness) Trials by year
6.2 Subjects Recruited for Onchocerciasis (River Blindness) Trials by Phase
6.3 Subjects Recruited for Onchocerciasis (River Blindness) Trials by Trial Type
6.4 Subjects Recruited for Onchocerciasis (River Blindness) Trials by Recruitment Status

7 Ongoing Trials- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company Details
7.1 Ongoing Onchocerciasis (River Blindness) Trials- Phase 1
7.2 Ongoing Onchocerciasis (River Blindness) Trials- Phase 2
7.3 Ongoing Onchocerciasis (River Blindness) Trials- Phase 3
7.4 Ongoing Onchocerciasis (River Blindness) Trials- Phase 4

8 Appendix
8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List of Figures
Figure 1: Onchocerciasis (River Blindness)- Clinical Trials by Country
Figure 2: Onchocerciasis (River Blindness)- Clinical Trials by Phase of Development, 2018
Figure 3: Onchocerciasis (River Blindness)- Clinical Trials by Status, 2018
Figure 4: Onchocerciasis (River Blindness)- Clinical Trials by Type, 2018
Figure 5: Onchocerciasis (River Blindness)- Clinical Trials Split by Region, 2000-2018
Figure 6: Onchocerciasis (River Blindness)- Clinical Trials by Type of Economy, 2018
Figure 7: Onchocerciasis (River Blindness)- Enrolment by Phase, 2018
Figure 8: Onchocerciasis (River Blindness)- Enrolment by Trial Type, 2018
Figure 9: Onchocerciasis (River Blindness)- Enrolment by Recruitment Status, 2018
Figure 10: Onchocerciasis (River Blindness)- Clinical Trials by Sponsor Type, 2018
Figure 11: Onchocerciasis (River Blindness)- Enrolment by Type of Sponsors
Figure 12: Onchocerciasis (River Blindness)- Enrolment by Leading Sponsors

List of Tables
Table 1: Onchocerciasis (River Blindness)- Clinical Trials by Sponsor Type, 2018
Table 2: Onchocerciasis (River Blindness)- Clinical Trials by Economy Type, 2018
Table 3: Onchocerciasis (River Blindness)- Clinical Trials by Region, 2018
Table 4: Onchocerciasis (River Blindness)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Onchocerciasis (River Blindness)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Onchocerciasis (River Blindness)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Onchocerciasis (River Blindness)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Onchocerciasis (River Blindness)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Onchocerciasis (River Blindness)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll